Related Experiment Video
Updated: Aug 6, 2025

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice
Xinzhi Li1, Ying Yang1, Zhenzhi Li1
1HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Aims/Hypothesis:
N6-methyladenosine (m6A) mRNA methylation and m6A-related proteins (methyltransferase-like 3 [METTL3], methyltransferase-like 14 [METTL14] and YTH domain containing 1 [YTHDC1]) have been shown to regulate islet beta cell function and the pathogenesis of diabetes. However, whether Wilms' tumour 1-associating protein (WTAP), a key regulator of the m6A RNA methyltransferase complex, regulates islet beta cell failure during pathogenesis of diabetes is largely unknown. The present study aimed to investigate the role of WTAP in the regulation of islet beta cell failure and diabetes.
Methods:
Islet beta cell-specific Wtap-knockout and beta cell-specific Mettl3-overexpressing mice were generated for this study. Blood glucose, glucose tolerance, serum insulin, glucose-stimulated insulin secretion (both in vivo and in vitro), insulin levels, glucagon levels and beta cell apoptosis were examined. RNA-seq and MeRIP-seq were performed, and the data were well analysed.
Results:
WTAP was downregulated in islet beta cells in type 2 diabetes, due to lipotoxicity and chronic inflammation, and islet beta cell-specific deletion of Wtap (Wtap-betaKO) induced beta cell failure and diabetes. Wtap-betaKO mice showed severe hyperglycaemia (above 20 mmol/l [360 mg/dl]) from 8 weeks of age onwards. Mechanistically, WTAP deficiency decreased m6A mRNA modification and reduced the expression of islet beta cell-specific transcription factors and insulin secretion-related genes by reducing METTL3 protein levels. Islet beta cell-specific overexpression of Mettl3 partially reversed the abnormalities observed in Wtap-betaKO mice.
Conclusions/Interpretation:
WTAP plays a key role in maintaining beta cell function by regulating m6A mRNA modification depending on METTL3, and the downregulation of WTAP leads to beta cell failure and diabetes.
Data Availability:
The RNA-seq and MeRIP-seq datasets generated during the current study are available in the Gene Expression Omnibus database repository ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215156 ; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215360 ).
Insights
Wilms
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Epigenetics
Background:
- N6-methyladenosine (m6A) mRNA methylation regulates islet beta cell function and diabetes pathogenesis.
- Key m6A regulators like METTL3, METTL14, and YTHDC1 are implicated, but the role of WTAP remains unclear.
Purpose of the Study:
- To investigate the role of Wilms' tumour 1-associating protein (WTAP) in islet beta cell failure and diabetes.
- To elucidate the mechanism by which WTAP influences beta cell function in the context of diabetes.
Main Methods:
- Generated islet beta cell-specific Wtap-knockout and Mettl3-overexpressing mouse models.
- Assessed glucose homeostasis, insulin secretion, and beta cell apoptosis.
- Utilized RNA-sequencing (RNA-seq) and m6A RNA immunoprecipitation sequencing (MeRIP-seq) for comprehensive analysis.
Main Results:
- WTAP was downregulated in type 2 diabetes islet beta cells, linked to lipotoxicity and inflammation.
- Deletion of WTAP in beta cells (Wtap-betaKO) led to severe hyperglycemia and beta cell failure.
- WTAP deficiency reduced m6A modification, decreased key beta cell transcription factors, and impaired insulin secretion via METTL3 downregulation.
Conclusions:
- WTAP is crucial for maintaining beta cell function through METTL3-dependent m6A modification.
- Downregulation of WTAP contributes to beta cell failure and the development of diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin Secretory Vesicles

